| Amount | Holding |
|---|---|
| 2.49% | Livongo Health, Inc |
| 2.22% | Quidel Corporation |
| 2.16% | DiaSorin S.p.A |
| 1.81% | Abiomed, Inc |
| 1.76% | Catalent, Inc |
| 1.67% | Illumina, Inc |
| 1.67% | |
| 1.62% | Teladoc Health, Inc |
| 1.59% | DexCom, Inc |
| 1.56% | Incyte Corporation |
Diversification Rating
7 /10
Expense Ratio Rating
7 /10
Expense Rating
3 /10
Market Score
1 /10
Category Score
0 /10
Market Size
1 /10
Robo Global Healthcare Technology and Innovation ETF
Expenses: 0.68% (Better than 1% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
| Amount | Holding |
|---|---|
| 2.49% | Livongo Health, Inc |
| 2.22% | Quidel Corporation |
| 2.16% | DiaSorin S.p.A |
| 1.81% | Abiomed, Inc |
| 1.76% | Catalent, Inc |
| 1.67% | Illumina, Inc |
| 1.67% | |
| 1.62% | Teladoc Health, Inc |
| 1.59% | DexCom, Inc |
| 1.56% | Incyte Corporation |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map